Every Form 4 that Option Care Health, Inc. (OPCH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow OPCH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OPCH filings page.
Bhatia Prateek reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health, Inc. executive vice president Prateek Bhatia reported receiving two stock awards of common stock as equity compensation. One award covered 23,409 shares, after which that line of ownership shows 39,795 shares directly held. A second award covered 16,386 shares, with that line showing 16,386 shares directly held after the grant.
The awards are in the form of restricted stock units that vest in stages. According to the filing, one third of the underlying shares vest on each of the first, second, and third anniversaries of the grant date, tying the compensation to continued service over three years.
Bierbower Elizabeth D reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health director Elizabeth D. Bierbower received an equity grant. She was awarded 8,997 shares of common stock as restricted stock units valued at $200,000, based on the closing price on May 20, 2026. These units vest in full on May 20, 2027, bringing her direct holdings to 32,871 shares.
Deckmann Natasha reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health, Inc. director Natasha Deckmann reported two equity awards of common stock on May 20, 2026. She received 8,997 restricted stock units that vest in full on May 20, 2027, granted in lieu of cash retainer payments. She also received an additional award of 844 restricted stock units, calculated to reflect $200,000 of value based on the closing share price on the grant date, which will also vest fully on May 20, 2027.
KRAEMER HARRY M JANSEN JR reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health director Harry M. Jansen Kraemer Jr. reported two stock-based compensation awards on common stock. He received 12,079 restricted stock units valued using a $200,000 target amount based on the May 20, 2026 closing price, plus 8,997 restricted stock units granted in lieu of cash retainer fees. Both awards vest in full on May 20, 2027 and represent equity compensation grants, not open-market purchases.
Pate R Carter reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health, Inc. director Pate R. Carter reported receiving an equity grant in the form of restricted stock units. The award covers 8,997 shares of common stock at a stated price of $0.00 per share and brings direct holdings to 20,620 shares after the transaction. A footnote explains the restricted stock units were valued at $200,000 based on the closing price on May 20, 2026, and they vest in full on May 20, 2027.
Option Care Health director Timothy P. Sullivan reported two stock awards from the company. On May 20, 2026 he acquired 4,836 shares of common stock at a reference price of $22.23 per share as a restricted stock unit award reflecting $200,000 of value. He also received 8,997 restricted stock units in lieu of cash retainer fees, with both grants based on the same closing share price. All these restricted stock units vest in full on May 20, 2027, representing routine equity-based director compensation rather than open-market share purchases.
Option Care Health director Barbara W. Bodem received an equity award of 8,997 common shares on May 20, 2026. The award represents restricted stock units valued at $200,000 based on the issuer’s closing share price on that date and carries no cash exercise cost.
The restricted stock units vest in full on May 20, 2027, meaning Bodem must remain in service through that date to receive the underlying shares. Following this grant, she beneficially owns 21,087 common shares directly, according to the filing.
Wright Norman L. reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health, Inc. director Norman L. Wright reported an equity award rather than a market trade. On May 20, 2026, he received 8,997 restricted stock units, designed to reflect $200,000 of value based on that day’s closing share price. These units vest in full on May 20, 2027, meaning he must remain eligible through that date to receive all shares. Following this award, Wright directly holds 24,498 shares of the company’s common stock.
Option Care Health director Eric Brandt reported equity awards of common stock as part of his compensation. On May 20, 2026 he acquired 2,643 shares of common stock at an indicated value of $22.23 per share through a grant classified as a “grant, award, or other acquisition.”
On the same date, he also received 8,997 restricted stock units in lieu of cash retainer payments, recorded at a price of $0.00 per share. Footnotes state one award was sized to represent $200,000 of value and that both RSU awards vest in full on May 20, 2027. Following these awards, Brandt directly holds 21,999 shares of Option Care Health common stock.
Option Care Health executive Collin Smyser reported routine equity compensation activity. On May 19, 2026, he exercised 812 Restricted Stock Units, converting them into the same number of common shares. In connection with this, 360 common shares were disposed of to satisfy tax obligations.
After these transactions, Smyser directly owned 75,012 common shares and indirectly held 2,500 common shares through a revocable trust. No open-market purchases or sales were reported, indicating these movements reflect compensation vesting and related tax withholding rather than discretionary trading.
Option Care Health, Inc. director Timothy P. Sullivan reported an open-market purchase of common stock. He bought 24,154 shares of Option Care Health at a weighted average price of $20.6869 per share, through multiple transactions with prices ranging from $20.47 to $20.69. Following these purchases, he directly owns 73,383 shares of the company’s common stock.
Option Care Health, Inc. director Harry M. Jansen Kraemer Jr. reported an open-market purchase of 36,610 shares of Common Stock on May 4, 2026. The shares were bought at a weighted average price of $21.4087 per share, with individual trade prices ranging from $21.35 to $21.475. Following this purchase, he directly owns 450,000 shares of Option Care Health, Inc.
Option Care Health, Inc. Chief Financial Officer Meenal Sethna bought 16,225 shares of common stock in an open-market purchase on May 4, 2026 at a weighted average price of $20.1587 per share.
The filing notes these shares were acquired through multiple trades at prices ranging from $19.94 to $20.38 per share. Following the transaction, Sethna directly owns 98,337 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Executive Officer John Charles Rademacher reported an open-market purchase of 12,500 shares of common stock on May 4, 2026 at a weighted average price of $21.1765 per share. Following this transaction, he directly owns 695,152 common shares.
The shares were bought in multiple trades that day at prices ranging from $21.14 to $21.18 per share, indicating a modest incremental increase to his existing equity stake in the company.
Option Care Health Chief Medical Officer Femi Adewunmi reported a tax-withholding disposition of 1,396 shares of Common Stock on April 22, 2026 at $28.38 per share. After this automatic withholding to cover tax obligations, Adewunmi directly holds 25,314 shares of Option Care Health Common Stock.
Option Care Health director Pate R. Carter reported an open-market sale of company stock. On February 27, 2026, Carter sold 30,287 shares of Option Care Health common stock at a weighted average price of $32.0474 per share in multiple trades, leaving 11,623 shares held directly.
Option Care Health, Inc. Chief Human Resources Officer Michael Bavaro reported an open-market sale of 6,000 shares of common stock at $33.00 per share. After this transaction, he directly owns 33,249 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Operating Officer Luke Whitworth reported a tax-related share disposition. On this Form 4, he transferred 4,605 shares of common stock at $33.815 per share to cover tax withholding, rather than executing an open-market sale. After this transaction, he directly holds 169,589 common shares.
Option Care Health Chief Growth Officer reports tax-related share disposition
Christopher L. Grashoff, Chief Growth Officer of Option Care Health, Inc., disposed of 1,980 shares of common stock on a tax-withholding basis at $33.815 per share. After this tax-withholding disposition, he directly holds 44,092 Option Care Health common shares.
Option Care Health, Inc. general counsel and corporate secretary Collin Smyser reported a Form 4 showing a tax-withholding disposition of 2,210 shares of common stock on February 24, 2026 at $33.815 per share. This was done to satisfy tax obligations by delivering shares rather than an open-market sale. Following this transaction, Smyser directly owned 74,560 common shares. An additional 2,500 common shares were held indirectly through a revocable trust after the reported date.
Option Care Health, Inc. Chief Medical Officer Adewunmi Femi reported a Form 4 transaction involving a tax-withholding disposition of 1,627 shares of common stock at an indicated price of $33.815 per share on February 24, 2026. After this transaction, Femi directly owned 26,710 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Executive Officer John Charles Rademacher used company stock to cover taxes on February 24, 2026. He disposed of 11,050 shares of common stock at $33.815 per share as a tax-withholding transaction and held 682,652 shares directly afterward.
Option Care Health, Inc. executive Michael Bavaro, the Chief Human Resources Officer, reported a disposition of company stock related to taxes. On this Form 4, he used 1,354 shares of common stock at $33.815 per share to cover a tax liability. After this tax-withholding transaction, he directly owned 39,249 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Accounting Officer Nicole Maggio reported a tax-withholding disposition of company stock. On February 24, 2026, she used 975 shares of common stock, valued at $33.815 per share, to satisfy tax obligations. After this transaction, she directly owned 28,489 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Human Resources Officer Michael Bavaro reported two tax-related share dispositions tied to equity compensation. On February 22, he disposed of 12,212 common shares at $35.69 per share to satisfy tax obligations. On February 20, he similarly disposed of 1,187 shares at $35.69 per share for tax withholding. These transactions are coded as tax-withholding events rather than open-market sales, and he continues to hold a meaningful number of shares directly.
Option Care Health, Inc. Chief Growth Officer Christopher L. Grashoff reported two tax-related share dispositions of company common stock. On February 20, 1,948 shares were disposed of at $35.69 per share to cover tax obligations, followed by 538 shares at the same price on February 22. After these tax-withholding dispositions, he directly owns 46,072 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Accounting Officer Nicole Maggio reported two tax-related share dispositions under a compensation plan. On February 20 and 22, she transferred a total of 991 shares of common stock at $35.69 per share to satisfy tax withholding obligations, a non-open-market transaction type coded as "F." After these transactions, she directly owned 29,464 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Operating Officer Luke Whitworth reported two tax-related share dispositions under an equity compensation arrangement. On February 22, 2026, 24,029 shares of common stock were delivered at $35.69 per share to cover taxes, leaving 174,194 shares directly held. On February 20, 2026, 4,015 shares were similarly withheld at $35.69 per share to satisfy tax obligations, after which 198,223 shares were reported as directly owned.
Option Care Health CEO John Charles Rademacher reported a mix of share acquisitions and tax-related dispositions. On February 21, 2026, he exercised 11,087 Restricted Stock Units, each converting into one share of common stock at a stated price of $0.0000 per share.
To cover tax obligations, he reported multiple F-code tax-withholding dispositions of common stock on February 20–22, 2026 at $35.69 per share. After these transactions, his direct ownership stood at 693,702 shares of common stock.
Option Care Health, Inc. reported insider transactions by its General Counsel and Corporate Secretary, Collin Smyser. On February 22, 2026, Smyser disposed of 15,433 shares of common stock at $35.69 per share, and on February 20, 2026, disposed of another 2,012 shares at the same price. Both transactions were coded “F,” meaning shares were surrendered to satisfy tax obligations rather than sold in open-market trades. After these transactions, Smyser held 76,770 shares directly, plus an additional 2,500 shares held indirectly through a revocable trust.
Option Care Health Chief Operating Officer Luke Whitworth reported two equity-related transactions in company common stock. He received a grant of 30,423 restricted stock units at no cost, which vest in three equal annual installments. Separately, 508 shares were disposed of to cover tax withholding obligations tied to equity compensation.
Option Care Health, Inc. Chief Growth Officer Christopher L. Grashoff reported mixed equity transactions. He received a grant of 12,678 shares of common stock at no cost as part of a restricted stock unit award. According to the footnote, one third of these units vest on each of the first three anniversaries of the grant date. Separately, 259 shares were disposed of at $35.24 per share to cover tax obligations associated with equity compensation, leaving him with 35,880 directly held shares after that tax-withholding transaction and 48,558 shares after the award grant.
Option Care Health, Inc. Chief Human Resources Officer Michael Bavaro reported two equity transactions. He acquired 9,579 shares of common stock as a restricted stock unit award at a stated price of $0.00 per share. These units vest in three equal annual installments beginning on the first anniversary of the grant date.
He also disposed of 551 shares of common stock at $35.24 per share in a tax-withholding transaction used to satisfy obligations associated with equity compensation. After these transactions, his directly held common stock balance reported in the filing increased compared with prior holdings.
Option Care Health Chief Accounting Officer reports equity grant and tax share withholding. Nicole Maggio received 4,226 shares of common stock on February 18, 2026 as a grant or award at a stated price of $0 per share, bringing her direct holdings to 30,455 shares after that grant.
On February 17, 2026, 247 shares of common stock were disposed of at $35.24 per share to satisfy tax withholding obligations, leaving 26,229 directly owned shares after that tax-related transaction. The footnote explains that the restricted stock units from this award vest in three equal installments on each of the first, second, and third anniversaries of the grant date.
Option Care Health, Inc. reported that Chief Executive Officer John Charles Rademacher acquired 78,876 shares of common stock through a grant of restricted stock units. The award was at a stated price of $0.00 per share and increases his directly held position to 831,057 shares. These restricted stock units vest in three equal annual installments on the first, second, and third anniversaries of the grant date.
Adewunmi Femi reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health, Inc. Chief Medical Officer Femi Adewunmi received a grant of 9,579 shares of common stock as an equity award. After this award, total directly held shares are 28,337. The restricted stock units vest in three equal annual installments on each of the first, second, and third anniversaries of the grant date.
Sethna Meenal reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health, Inc. Chief Financial Officer Meenal Sethna reported an equity award of 27,045 shares of common stock, received as a grant with no cash price per share. These restricted stock units vest in three equal annual installments, and her directly held common stock increased to 82,112 shares after the award.
Option Care Health, Inc. reported that General Counsel and Corporate Secretary Collin Smyser acquired 15,213 shares of common stock through an equity award coded as a grant or other acquisition. The award consists of restricted stock units that vest in three equal installments on each of the first, second, and third anniversaries of the grant date.
After this grant, Smyser directly owns 94,215 shares of common stock. In addition, 2,500 shares are held indirectly through a revocable trust, reflecting separate indirect ownership.
Option Care Health (OPCH) reported an insider purchase by a director. On November 3, 2025, the reporting person bought 38,000 shares of common stock at a weighted average price of $25.984 per share, executed across multiple trades priced between $25.835 and $26.235.
Following this transaction, the director beneficially owned 413,390 shares, held directly. The filing notes the weighted average and offers to provide detailed trade-by-trade pricing upon request.
Option Care Health reported a Form 4 disclosing that Meenal Sethna, the company’s Chief Financial Officer, received an award of 55,067 restricted stock units in a transaction dated 10/01/2025. The units were issued at a price of $0 and are shown as directly beneficially owned at 55,067 shares following the award. The filing notes the restricted stock units "vest on the third anniversary of the grant date," and the Form 4 was signed on behalf of Ms. Sethna by an attorney-in-fact on 10/03/2025. The disclosure is a standard insider compensation award reported under Section 16 rules and contains no additional financial results, sales, or derivative transactions.